Global HER2 Target Drugs Market Growth 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
According to our LPI (LP Information) latest study, the global HER2 Target Drugs market size was valued at US$ million in 2022. With growing demand in downstream market, the HER2 Target Drugs is forecast to a readjusted size of US$ million by 2029 with a CAGR of % during review period.
The research report highlights the growth potential of the global HER2 Target Drugs market. HER2 Target Drugs are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of HER2 Target Drugs. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the HER2 Target Drugs market.
Activation of the epidermal growth factor receptor (EGFR) family of transmembrane receptor tyrosine kinases can regulate signaling pathways for cell proliferation and survival. HER2 is a non-ligand-binding member of this family and exerts its activity through heterodimerization with other EGFR family members. Activation of HER2 function can promote tumorigenesis, so scientists have begun research on HER2-targeted drugs in HER2 gene-related cancers.
Key Features:
The report on HER2 Target Drugs market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the HER2 Target Drugs market. It may include historical data, market segmentation by Type (e.g., Monoclonal Antibodies, Small Molecule Chemicals), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the HER2 Target Drugs market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the HER2 Target Drugs market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the HER2 Target Drugs industry. This include advancements in HER2 Target Drugs technology, HER2 Target Drugs new entrants, HER2 Target Drugs new investment, and other innovations that are shaping the future of HER2 Target Drugs.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the HER2 Target Drugs market. It includes factors influencing customer ' purchasing decisions, preferences for HER2 Target Drugs product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the HER2 Target Drugs market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting HER2 Target Drugs market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the HER2 Target Drugs market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the HER2 Target Drugs industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the HER2 Target Drugs market.
Market Segmentation:
HER2 Target Drugs market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Segmentation by type
What is the 10-year outlook for the global HER2 Target Drugs market?
What factors are driving HER2 Target Drugs market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do HER2 Target Drugs market opportunities vary by end market size?
How does HER2 Target Drugs break out type, application?
According to our LPI (LP Information) latest study, the global HER2 Target Drugs market size was valued at US$ million in 2022. With growing demand in downstream market, the HER2 Target Drugs is forecast to a readjusted size of US$ million by 2029 with a CAGR of % during review period.
The research report highlights the growth potential of the global HER2 Target Drugs market. HER2 Target Drugs are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of HER2 Target Drugs. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the HER2 Target Drugs market.
Activation of the epidermal growth factor receptor (EGFR) family of transmembrane receptor tyrosine kinases can regulate signaling pathways for cell proliferation and survival. HER2 is a non-ligand-binding member of this family and exerts its activity through heterodimerization with other EGFR family members. Activation of HER2 function can promote tumorigenesis, so scientists have begun research on HER2-targeted drugs in HER2 gene-related cancers.
Key Features:
The report on HER2 Target Drugs market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the HER2 Target Drugs market. It may include historical data, market segmentation by Type (e.g., Monoclonal Antibodies, Small Molecule Chemicals), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the HER2 Target Drugs market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the HER2 Target Drugs market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the HER2 Target Drugs industry. This include advancements in HER2 Target Drugs technology, HER2 Target Drugs new entrants, HER2 Target Drugs new investment, and other innovations that are shaping the future of HER2 Target Drugs.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the HER2 Target Drugs market. It includes factors influencing customer ' purchasing decisions, preferences for HER2 Target Drugs product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the HER2 Target Drugs market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting HER2 Target Drugs market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the HER2 Target Drugs market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the HER2 Target Drugs industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the HER2 Target Drugs market.
Market Segmentation:
HER2 Target Drugs market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Segmentation by type
- Monoclonal Antibodies
- Small Molecule Chemicals
- Antibody Drug Conjugate
- Breast Cancer
- Colorectal Cancer
- Stomach Cancer
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Roche
- GSK
- Boehringer Digelheim
- Pfizer
- AstraZeneca
- Seagen
- MacroGenics
- Takeda
- Daiichi Sankyo
- Novartis AG
- RemeGen
- Sunshine Guojian
- Hengrui Medicine
What is the 10-year outlook for the global HER2 Target Drugs market?
What factors are driving HER2 Target Drugs market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do HER2 Target Drugs market opportunities vary by end market size?
How does HER2 Target Drugs break out type, application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global HER2 Target Drugs Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for HER2 Target Drugs by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for HER2 Target Drugs by Country/Region, 2018, 2022 & 2029
2.2 HER2 Target Drugs Segment by Type
2.2.1 Monoclonal Antibodies
2.2.2 Small Molecule Chemicals
2.2.3 Antibody Drug Conjugate
2.3 HER2 Target Drugs Sales by Type
2.3.1 Global HER2 Target Drugs Sales Market Share by Type (2018-2023)
2.3.2 Global HER2 Target Drugs Revenue and Market Share by Type (2018-2023)
2.3.3 Global HER2 Target Drugs Sale Price by Type (2018-2023)
2.4 HER2 Target Drugs Segment by Application
2.4.1 Breast Cancer
2.4.2 Colorectal Cancer
2.4.3 Stomach Cancer
2.4.4 Other
2.5 HER2 Target Drugs Sales by Application
2.5.1 Global HER2 Target Drugs Sale Market Share by Application (2018-2023)
2.5.2 Global HER2 Target Drugs Revenue and Market Share by Application (2018-2023)
2.5.3 Global HER2 Target Drugs Sale Price by Application (2018-2023)
3 GLOBAL HER2 TARGET DRUGS BY COMPANY
3.1 Global HER2 Target Drugs Breakdown Data by Company
3.1.1 Global HER2 Target Drugs Annual Sales by Company (2018-2023)
3.1.2 Global HER2 Target Drugs Sales Market Share by Company (2018-2023)
3.2 Global HER2 Target Drugs Annual Revenue by Company (2018-2023)
3.2.1 Global HER2 Target Drugs Revenue by Company (2018-2023)
3.2.2 Global HER2 Target Drugs Revenue Market Share by Company (2018-2023)
3.3 Global HER2 Target Drugs Sale Price by Company
3.4 Key Manufacturers HER2 Target Drugs Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers HER2 Target Drugs Product Location Distribution
3.4.2 Players HER2 Target Drugs Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR HER2 TARGET DRUGS BY GEOGRAPHIC REGION
4.1 World Historic HER2 Target Drugs Market Size by Geographic Region (2018-2023)
4.1.1 Global HER2 Target Drugs Annual Sales by Geographic Region (2018-2023)
4.1.2 Global HER2 Target Drugs Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic HER2 Target Drugs Market Size by Country/Region (2018-2023)
4.2.1 Global HER2 Target Drugs Annual Sales by Country/Region (2018-2023)
4.2.2 Global HER2 Target Drugs Annual Revenue by Country/Region (2018-2023)
4.3 Americas HER2 Target Drugs Sales Growth
4.4 APAC HER2 Target Drugs Sales Growth
4.5 Europe HER2 Target Drugs Sales Growth
4.6 Middle East & Africa HER2 Target Drugs Sales Growth
5 AMERICAS
5.1 Americas HER2 Target Drugs Sales by Country
5.1.1 Americas HER2 Target Drugs Sales by Country (2018-2023)
5.1.2 Americas HER2 Target Drugs Revenue by Country (2018-2023)
5.2 Americas HER2 Target Drugs Sales by Type
5.3 Americas HER2 Target Drugs Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC HER2 Target Drugs Sales by Region
6.1.1 APAC HER2 Target Drugs Sales by Region (2018-2023)
6.1.2 APAC HER2 Target Drugs Revenue by Region (2018-2023)
6.2 APAC HER2 Target Drugs Sales by Type
6.3 APAC HER2 Target Drugs Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe HER2 Target Drugs by Country
7.1.1 Europe HER2 Target Drugs Sales by Country (2018-2023)
7.1.2 Europe HER2 Target Drugs Revenue by Country (2018-2023)
7.2 Europe HER2 Target Drugs Sales by Type
7.3 Europe HER2 Target Drugs Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa HER2 Target Drugs by Country
8.1.1 Middle East & Africa HER2 Target Drugs Sales by Country (2018-2023)
8.1.2 Middle East & Africa HER2 Target Drugs Revenue by Country (2018-2023)
8.2 Middle East & Africa HER2 Target Drugs Sales by Type
8.3 Middle East & Africa HER2 Target Drugs Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of HER2 Target Drugs
10.3 Manufacturing Process Analysis of HER2 Target Drugs
10.4 Industry Chain Structure of HER2 Target Drugs
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 HER2 Target Drugs Distributors
11.3 HER2 Target Drugs Customer
12 WORLD FORECAST REVIEW FOR HER2 TARGET DRUGS BY GEOGRAPHIC REGION
12.1 Global HER2 Target Drugs Market Size Forecast by Region
12.1.1 Global HER2 Target Drugs Forecast by Region (2024-2029)
12.1.2 Global HER2 Target Drugs Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global HER2 Target Drugs Forecast by Type
12.7 Global HER2 Target Drugs Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Roche
13.1.1 Roche Company Information
13.1.2 Roche HER2 Target Drugs Product Portfolios and Specifications
13.1.3 Roche HER2 Target Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Roche Main Business Overview
13.1.5 Roche Latest Developments
13.2 GSK
13.2.1 GSK Company Information
13.2.2 GSK HER2 Target Drugs Product Portfolios and Specifications
13.2.3 GSK HER2 Target Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 GSK Main Business Overview
13.2.5 GSK Latest Developments
13.3 Boehringer Digelheim
13.3.1 Boehringer Digelheim Company Information
13.3.2 Boehringer Digelheim HER2 Target Drugs Product Portfolios and Specifications
13.3.3 Boehringer Digelheim HER2 Target Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Boehringer Digelheim Main Business Overview
13.3.5 Boehringer Digelheim Latest Developments
13.4 Pfizer
13.4.1 Pfizer Company Information
13.4.2 Pfizer HER2 Target Drugs Product Portfolios and Specifications
13.4.3 Pfizer HER2 Target Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Pfizer Main Business Overview
13.4.5 Pfizer Latest Developments
13.5 AstraZeneca
13.5.1 AstraZeneca Company Information
13.5.2 AstraZeneca HER2 Target Drugs Product Portfolios and Specifications
13.5.3 AstraZeneca HER2 Target Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 AstraZeneca Main Business Overview
13.5.5 AstraZeneca Latest Developments
13.6 Seagen
13.6.1 Seagen Company Information
13.6.2 Seagen HER2 Target Drugs Product Portfolios and Specifications
13.6.3 Seagen HER2 Target Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Seagen Main Business Overview
13.6.5 Seagen Latest Developments
13.7 MacroGenics
13.7.1 MacroGenics Company Information
13.7.2 MacroGenics HER2 Target Drugs Product Portfolios and Specifications
13.7.3 MacroGenics HER2 Target Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 MacroGenics Main Business Overview
13.7.5 MacroGenics Latest Developments
13.8 Takeda
13.8.1 Takeda Company Information
13.8.2 Takeda HER2 Target Drugs Product Portfolios and Specifications
13.8.3 Takeda HER2 Target Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Takeda Main Business Overview
13.8.5 Takeda Latest Developments
13.9 Daiichi Sankyo
13.9.1 Daiichi Sankyo Company Information
13.9.2 Daiichi Sankyo HER2 Target Drugs Product Portfolios and Specifications
13.9.3 Daiichi Sankyo HER2 Target Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Daiichi Sankyo Main Business Overview
13.9.5 Daiichi Sankyo Latest Developments
13.10 Novartis AG
13.10.1 Novartis AG Company Information
13.10.2 Novartis AG HER2 Target Drugs Product Portfolios and Specifications
13.10.3 Novartis AG HER2 Target Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Novartis AG Main Business Overview
13.10.5 Novartis AG Latest Developments
13.11 RemeGen
13.11.1 RemeGen Company Information
13.11.2 RemeGen HER2 Target Drugs Product Portfolios and Specifications
13.11.3 RemeGen HER2 Target Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 RemeGen Main Business Overview
13.11.5 RemeGen Latest Developments
13.12 Sunshine Guojian
13.12.1 Sunshine Guojian Company Information
13.12.2 Sunshine Guojian HER2 Target Drugs Product Portfolios and Specifications
13.12.3 Sunshine Guojian HER2 Target Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 Sunshine Guojian Main Business Overview
13.12.5 Sunshine Guojian Latest Developments
13.13 Hengrui Medicine
13.13.1 Hengrui Medicine Company Information
13.13.2 Hengrui Medicine HER2 Target Drugs Product Portfolios and Specifications
13.13.3 Hengrui Medicine HER2 Target Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 Hengrui Medicine Main Business Overview
13.13.5 Hengrui Medicine Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global HER2 Target Drugs Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for HER2 Target Drugs by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for HER2 Target Drugs by Country/Region, 2018, 2022 & 2029
2.2 HER2 Target Drugs Segment by Type
2.2.1 Monoclonal Antibodies
2.2.2 Small Molecule Chemicals
2.2.3 Antibody Drug Conjugate
2.3 HER2 Target Drugs Sales by Type
2.3.1 Global HER2 Target Drugs Sales Market Share by Type (2018-2023)
2.3.2 Global HER2 Target Drugs Revenue and Market Share by Type (2018-2023)
2.3.3 Global HER2 Target Drugs Sale Price by Type (2018-2023)
2.4 HER2 Target Drugs Segment by Application
2.4.1 Breast Cancer
2.4.2 Colorectal Cancer
2.4.3 Stomach Cancer
2.4.4 Other
2.5 HER2 Target Drugs Sales by Application
2.5.1 Global HER2 Target Drugs Sale Market Share by Application (2018-2023)
2.5.2 Global HER2 Target Drugs Revenue and Market Share by Application (2018-2023)
2.5.3 Global HER2 Target Drugs Sale Price by Application (2018-2023)
3 GLOBAL HER2 TARGET DRUGS BY COMPANY
3.1 Global HER2 Target Drugs Breakdown Data by Company
3.1.1 Global HER2 Target Drugs Annual Sales by Company (2018-2023)
3.1.2 Global HER2 Target Drugs Sales Market Share by Company (2018-2023)
3.2 Global HER2 Target Drugs Annual Revenue by Company (2018-2023)
3.2.1 Global HER2 Target Drugs Revenue by Company (2018-2023)
3.2.2 Global HER2 Target Drugs Revenue Market Share by Company (2018-2023)
3.3 Global HER2 Target Drugs Sale Price by Company
3.4 Key Manufacturers HER2 Target Drugs Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers HER2 Target Drugs Product Location Distribution
3.4.2 Players HER2 Target Drugs Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR HER2 TARGET DRUGS BY GEOGRAPHIC REGION
4.1 World Historic HER2 Target Drugs Market Size by Geographic Region (2018-2023)
4.1.1 Global HER2 Target Drugs Annual Sales by Geographic Region (2018-2023)
4.1.2 Global HER2 Target Drugs Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic HER2 Target Drugs Market Size by Country/Region (2018-2023)
4.2.1 Global HER2 Target Drugs Annual Sales by Country/Region (2018-2023)
4.2.2 Global HER2 Target Drugs Annual Revenue by Country/Region (2018-2023)
4.3 Americas HER2 Target Drugs Sales Growth
4.4 APAC HER2 Target Drugs Sales Growth
4.5 Europe HER2 Target Drugs Sales Growth
4.6 Middle East & Africa HER2 Target Drugs Sales Growth
5 AMERICAS
5.1 Americas HER2 Target Drugs Sales by Country
5.1.1 Americas HER2 Target Drugs Sales by Country (2018-2023)
5.1.2 Americas HER2 Target Drugs Revenue by Country (2018-2023)
5.2 Americas HER2 Target Drugs Sales by Type
5.3 Americas HER2 Target Drugs Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC HER2 Target Drugs Sales by Region
6.1.1 APAC HER2 Target Drugs Sales by Region (2018-2023)
6.1.2 APAC HER2 Target Drugs Revenue by Region (2018-2023)
6.2 APAC HER2 Target Drugs Sales by Type
6.3 APAC HER2 Target Drugs Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe HER2 Target Drugs by Country
7.1.1 Europe HER2 Target Drugs Sales by Country (2018-2023)
7.1.2 Europe HER2 Target Drugs Revenue by Country (2018-2023)
7.2 Europe HER2 Target Drugs Sales by Type
7.3 Europe HER2 Target Drugs Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa HER2 Target Drugs by Country
8.1.1 Middle East & Africa HER2 Target Drugs Sales by Country (2018-2023)
8.1.2 Middle East & Africa HER2 Target Drugs Revenue by Country (2018-2023)
8.2 Middle East & Africa HER2 Target Drugs Sales by Type
8.3 Middle East & Africa HER2 Target Drugs Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of HER2 Target Drugs
10.3 Manufacturing Process Analysis of HER2 Target Drugs
10.4 Industry Chain Structure of HER2 Target Drugs
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 HER2 Target Drugs Distributors
11.3 HER2 Target Drugs Customer
12 WORLD FORECAST REVIEW FOR HER2 TARGET DRUGS BY GEOGRAPHIC REGION
12.1 Global HER2 Target Drugs Market Size Forecast by Region
12.1.1 Global HER2 Target Drugs Forecast by Region (2024-2029)
12.1.2 Global HER2 Target Drugs Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global HER2 Target Drugs Forecast by Type
12.7 Global HER2 Target Drugs Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Roche
13.1.1 Roche Company Information
13.1.2 Roche HER2 Target Drugs Product Portfolios and Specifications
13.1.3 Roche HER2 Target Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Roche Main Business Overview
13.1.5 Roche Latest Developments
13.2 GSK
13.2.1 GSK Company Information
13.2.2 GSK HER2 Target Drugs Product Portfolios and Specifications
13.2.3 GSK HER2 Target Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 GSK Main Business Overview
13.2.5 GSK Latest Developments
13.3 Boehringer Digelheim
13.3.1 Boehringer Digelheim Company Information
13.3.2 Boehringer Digelheim HER2 Target Drugs Product Portfolios and Specifications
13.3.3 Boehringer Digelheim HER2 Target Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Boehringer Digelheim Main Business Overview
13.3.5 Boehringer Digelheim Latest Developments
13.4 Pfizer
13.4.1 Pfizer Company Information
13.4.2 Pfizer HER2 Target Drugs Product Portfolios and Specifications
13.4.3 Pfizer HER2 Target Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Pfizer Main Business Overview
13.4.5 Pfizer Latest Developments
13.5 AstraZeneca
13.5.1 AstraZeneca Company Information
13.5.2 AstraZeneca HER2 Target Drugs Product Portfolios and Specifications
13.5.3 AstraZeneca HER2 Target Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 AstraZeneca Main Business Overview
13.5.5 AstraZeneca Latest Developments
13.6 Seagen
13.6.1 Seagen Company Information
13.6.2 Seagen HER2 Target Drugs Product Portfolios and Specifications
13.6.3 Seagen HER2 Target Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Seagen Main Business Overview
13.6.5 Seagen Latest Developments
13.7 MacroGenics
13.7.1 MacroGenics Company Information
13.7.2 MacroGenics HER2 Target Drugs Product Portfolios and Specifications
13.7.3 MacroGenics HER2 Target Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 MacroGenics Main Business Overview
13.7.5 MacroGenics Latest Developments
13.8 Takeda
13.8.1 Takeda Company Information
13.8.2 Takeda HER2 Target Drugs Product Portfolios and Specifications
13.8.3 Takeda HER2 Target Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Takeda Main Business Overview
13.8.5 Takeda Latest Developments
13.9 Daiichi Sankyo
13.9.1 Daiichi Sankyo Company Information
13.9.2 Daiichi Sankyo HER2 Target Drugs Product Portfolios and Specifications
13.9.3 Daiichi Sankyo HER2 Target Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Daiichi Sankyo Main Business Overview
13.9.5 Daiichi Sankyo Latest Developments
13.10 Novartis AG
13.10.1 Novartis AG Company Information
13.10.2 Novartis AG HER2 Target Drugs Product Portfolios and Specifications
13.10.3 Novartis AG HER2 Target Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Novartis AG Main Business Overview
13.10.5 Novartis AG Latest Developments
13.11 RemeGen
13.11.1 RemeGen Company Information
13.11.2 RemeGen HER2 Target Drugs Product Portfolios and Specifications
13.11.3 RemeGen HER2 Target Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 RemeGen Main Business Overview
13.11.5 RemeGen Latest Developments
13.12 Sunshine Guojian
13.12.1 Sunshine Guojian Company Information
13.12.2 Sunshine Guojian HER2 Target Drugs Product Portfolios and Specifications
13.12.3 Sunshine Guojian HER2 Target Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 Sunshine Guojian Main Business Overview
13.12.5 Sunshine Guojian Latest Developments
13.13 Hengrui Medicine
13.13.1 Hengrui Medicine Company Information
13.13.2 Hengrui Medicine HER2 Target Drugs Product Portfolios and Specifications
13.13.3 Hengrui Medicine HER2 Target Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 Hengrui Medicine Main Business Overview
13.13.5 Hengrui Medicine Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. HER2 Target Drugs Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. HER2 Target Drugs Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Monoclonal Antibodies
Table 4. Major Players of Small Molecule Chemicals
Table 5. Major Players of Antibody Drug Conjugate
Table 6. Global HER2 Target Drugs Sales by Type (2018-2023) & (K Units)
Table 7. Global HER2 Target Drugs Sales Market Share by Type (2018-2023)
Table 8. Global HER2 Target Drugs Revenue by Type (2018-2023) & ($ million)
Table 9. Global HER2 Target Drugs Revenue Market Share by Type (2018-2023)
Table 10. Global HER2 Target Drugs Sale Price by Type (2018-2023) & (US$/Unit)
Table 11. Global HER2 Target Drugs Sales by Application (2018-2023) & (K Units)
Table 12. Global HER2 Target Drugs Sales Market Share by Application (2018-2023)
Table 13. Global HER2 Target Drugs Revenue by Application (2018-2023)
Table 14. Global HER2 Target Drugs Revenue Market Share by Application (2018-2023)
Table 15. Global HER2 Target Drugs Sale Price by Application (2018-2023) & (US$/Unit)
Table 16. Global HER2 Target Drugs Sales by Company (2018-2023) & (K Units)
Table 17. Global HER2 Target Drugs Sales Market Share by Company (2018-2023)
Table 18. Global HER2 Target Drugs Revenue by Company (2018-2023) ($ Millions)
Table 19. Global HER2 Target Drugs Revenue Market Share by Company (2018-2023)
Table 20. Global HER2 Target Drugs Sale Price by Company (2018-2023) & (US$/Unit)
Table 21. Key Manufacturers HER2 Target Drugs Producing Area Distribution and Sales Area
Table 22. Players HER2 Target Drugs Products Offered
Table 23. HER2 Target Drugs Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global HER2 Target Drugs Sales by Geographic Region (2018-2023) & (K Units)
Table 27. Global HER2 Target Drugs Sales Market Share Geographic Region (2018-2023)
Table 28. Global HER2 Target Drugs Revenue by Geographic Region (2018-2023) & ($ millions)
Table 29. Global HER2 Target Drugs Revenue Market Share by Geographic Region (2018-2023)
Table 30. Global HER2 Target Drugs Sales by Country/Region (2018-2023) & (K Units)
Table 31. Global HER2 Target Drugs Sales Market Share by Country/Region (2018-2023)
Table 32. Global HER2 Target Drugs Revenue by Country/Region (2018-2023) & ($ millions)
Table 33. Global HER2 Target Drugs Revenue Market Share by Country/Region (2018-2023)
Table 34. Americas HER2 Target Drugs Sales by Country (2018-2023) & (K Units)
Table 35. Americas HER2 Target Drugs Sales Market Share by Country (2018-2023)
Table 36. Americas HER2 Target Drugs Revenue by Country (2018-2023) & ($ Millions)
Table 37. Americas HER2 Target Drugs Revenue Market Share by Country (2018-2023)
Table 38. Americas HER2 Target Drugs Sales by Type (2018-2023) & (K Units)
Table 39. Americas HER2 Target Drugs Sales by Application (2018-2023) & (K Units)
Table 40. APAC HER2 Target Drugs Sales by Region (2018-2023) & (K Units)
Table 41. APAC HER2 Target Drugs Sales Market Share by Region (2018-2023)
Table 42. APAC HER2 Target Drugs Revenue by Region (2018-2023) & ($ Millions)
Table 43. APAC HER2 Target Drugs Revenue Market Share by Region (2018-2023)
Table 44. APAC HER2 Target Drugs Sales by Type (2018-2023) & (K Units)
Table 45. APAC HER2 Target Drugs Sales by Application (2018-2023) & (K Units)
Table 46. Europe HER2 Target Drugs Sales by Country (2018-2023) & (K Units)
Table 47. Europe HER2 Target Drugs Sales Market Share by Country (2018-2023)
Table 48. Europe HER2 Target Drugs Revenue by Country (2018-2023) & ($ Millions)
Table 49. Europe HER2 Target Drugs Revenue Market Share by Country (2018-2023)
Table 50. Europe HER2 Target Drugs Sales by Type (2018-2023) & (K Units)
Table 51. Europe HER2 Target Drugs Sales by Application (2018-2023) & (K Units)
Table 52. Middle East & Africa HER2 Target Drugs Sales by Country (2018-2023) & (K Units)
Table 53. Middle East & Africa HER2 Target Drugs Sales Market Share by Country (2018-2023)
Table 54. Middle East & Africa HER2 Target Drugs Revenue by Country (2018-2023) & ($ Millions)
Table 55. Middle East & Africa HER2 Target Drugs Revenue Market Share by Country (2018-2023)
Table 56. Middle East & Africa HER2 Target Drugs Sales by Type (2018-2023) & (K Units)
Table 57. Middle East & Africa HER2 Target Drugs Sales by Application (2018-2023) & (K Units)
Table 58. Key Market Drivers & Growth Opportunities of HER2 Target Drugs
Table 59. Key Market Challenges & Risks of HER2 Target Drugs
Table 60. Key Industry Trends of HER2 Target Drugs
Table 61. HER2 Target Drugs Raw Material
Table 62. Key Suppliers of Raw Materials
Table 63. HER2 Target Drugs Distributors List
Table 64. HER2 Target Drugs Customer List
Table 65. Global HER2 Target Drugs Sales Forecast by Region (2024-2029) & (K Units)
Table 66. Global HER2 Target Drugs Revenue Forecast by Region (2024-2029) & ($ millions)
Table 67. Americas HER2 Target Drugs Sales Forecast by Country (2024-2029) & (K Units)
Table 68. Americas HER2 Target Drugs Revenue Forecast by Country (2024-2029) & ($ millions)
Table 69. APAC HER2 Target Drugs Sales Forecast by Region (2024-2029) & (K Units)
Table 70. APAC HER2 Target Drugs Revenue Forecast by Region (2024-2029) & ($ millions)
Table 71. Europe HER2 Target Drugs Sales Forecast by Country (2024-2029) & (K Units)
Table 72. Europe HER2 Target Drugs Revenue Forecast by Country (2024-2029) & ($ millions)
Table 73. Middle East & Africa HER2 Target Drugs Sales Forecast by Country (2024-2029) & (K Units)
Table 74. Middle East & Africa HER2 Target Drugs Revenue Forecast by Country (2024-2029) & ($ millions)
Table 75. Global HER2 Target Drugs Sales Forecast by Type (2024-2029) & (K Units)
Table 76. Global HER2 Target Drugs Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 77. Global HER2 Target Drugs Sales Forecast by Application (2024-2029) & (K Units)
Table 78. Global HER2 Target Drugs Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 79. Roche Basic Information, HER2 Target Drugs Manufacturing Base, Sales Area and Its Competitors
Table 80. Roche HER2 Target Drugs Product Portfolios and Specifications
Table 81. Roche HER2 Target Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 82. Roche Main Business
Table 83. Roche Latest Developments
Table 84. GSK Basic Information, HER2 Target Drugs Manufacturing Base, Sales Area and Its Competitors
Table 85. GSK HER2 Target Drugs Product Portfolios and Specifications
Table 86. GSK HER2 Target Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 87. GSK Main Business
Table 88. GSK Latest Developments
Table 89. Boehringer Digelheim Basic Information, HER2 Target Drugs Manufacturing Base, Sales Area and Its Competitors
Table 90. Boehringer Digelheim HER2 Target Drugs Product Portfolios and Specifications
Table 91. Boehringer Digelheim HER2 Target Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 92. Boehringer Digelheim Main Business
Table 93. Boehringer Digelheim Latest Developments
Table 94. Pfizer Basic Information, HER2 Target Drugs Manufacturing Base, Sales Area and Its Competitors
Table 95. Pfizer HER2 Target Drugs Product Portfolios and Specifications
Table 96. Pfizer HER2 Target Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 97. Pfizer Main Business
Table 98. Pfizer Latest Developments
Table 99. AstraZeneca Basic Information, HER2 Target Drugs Manufacturing Base, Sales Area and Its Competitors
Table 100. AstraZeneca HER2 Target Drugs Product Portfolios and Specifications
Table 101. AstraZeneca HER2 Target Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 102. AstraZeneca Main Business
Table 103. AstraZeneca Latest Developments
Table 104. Seagen Basic Information, HER2 Target Drugs Manufacturing Base, Sales Area and Its Competitors
Table 105. Seagen HER2 Target Drugs Product Portfolios and Specifications
Table 106. Seagen HER2 Target Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 107. Seagen Main Business
Table 108. Seagen Latest Developments
Table 109. MacroGenics Basic Information, HER2 Target Drugs Manufacturing Base, Sales Area and Its Competitors
Table 110. MacroGenics HER2 Target Drugs Product Portfolios and Specifications
Table 111. MacroGenics HER2 Target Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 112. MacroGenics Main Business
Table 113. MacroGenics Latest Developments
Table 114. Takeda Basic Information, HER2 Target Drugs Manufacturing Base, Sales Area and Its Competitors
Table 115. Takeda HER2 Target Drugs Product Portfolios and Specifications
Table 116. Takeda HER2 Target Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 117. Takeda Main Business
Table 118. Takeda Latest Developments
Table 119. Daiichi Sankyo Basic Information, HER2 Target Drugs Manufacturing Base, Sales Area and Its Competitors
Table 120. Daiichi Sankyo HER2 Target Drugs Product Portfolios and Specifications
Table 121. Daiichi Sankyo HER2 Target Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 122. Daiichi Sankyo Main Business
Table 123. Daiichi Sankyo Latest Developments
Table 124. Novartis AG Basic Information, HER2 Target Drugs Manufacturing Base, Sales Area and Its Competitors
Table 125. Novartis AG HER2 Target Drugs Product Portfolios and Specifications
Table 126. Novartis AG HER2 Target Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 127. Novartis AG Main Business
Table 128. Novartis AG Latest Developments
Table 129. RemeGen Basic Information, HER2 Target Drugs Manufacturing Base, Sales Area and Its Competitors
Table 130. RemeGen HER2 Target Drugs Product Portfolios and Specifications
Table 131. RemeGen HER2 Target Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 132. RemeGen Main Business
Table 133. RemeGen Latest Developments
Table 134. Sunshine Guojian Basic Information, HER2 Target Drugs Manufacturing Base, Sales Area and Its Competitors
Table 135. Sunshine Guojian HER2 Target Drugs Product Portfolios and Specifications
Table 136. Sunshine Guojian HER2 Target Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 137. Sunshine Guojian Main Business
Table 138. Sunshine Guojian Latest Developments
Table 139. Hengrui Medicine Basic Information, HER2 Target Drugs Manufacturing Base, Sales Area and Its Competitors
Table 140. Hengrui Medicine HER2 Target Drugs Product Portfolios and Specifications
Table 141. Hengrui Medicine HER2 Target Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 142. Hengrui Medicine Main Business
Table 143. Hengrui Medicine Latest Developments
Table 1. HER2 Target Drugs Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. HER2 Target Drugs Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Monoclonal Antibodies
Table 4. Major Players of Small Molecule Chemicals
Table 5. Major Players of Antibody Drug Conjugate
Table 6. Global HER2 Target Drugs Sales by Type (2018-2023) & (K Units)
Table 7. Global HER2 Target Drugs Sales Market Share by Type (2018-2023)
Table 8. Global HER2 Target Drugs Revenue by Type (2018-2023) & ($ million)
Table 9. Global HER2 Target Drugs Revenue Market Share by Type (2018-2023)
Table 10. Global HER2 Target Drugs Sale Price by Type (2018-2023) & (US$/Unit)
Table 11. Global HER2 Target Drugs Sales by Application (2018-2023) & (K Units)
Table 12. Global HER2 Target Drugs Sales Market Share by Application (2018-2023)
Table 13. Global HER2 Target Drugs Revenue by Application (2018-2023)
Table 14. Global HER2 Target Drugs Revenue Market Share by Application (2018-2023)
Table 15. Global HER2 Target Drugs Sale Price by Application (2018-2023) & (US$/Unit)
Table 16. Global HER2 Target Drugs Sales by Company (2018-2023) & (K Units)
Table 17. Global HER2 Target Drugs Sales Market Share by Company (2018-2023)
Table 18. Global HER2 Target Drugs Revenue by Company (2018-2023) ($ Millions)
Table 19. Global HER2 Target Drugs Revenue Market Share by Company (2018-2023)
Table 20. Global HER2 Target Drugs Sale Price by Company (2018-2023) & (US$/Unit)
Table 21. Key Manufacturers HER2 Target Drugs Producing Area Distribution and Sales Area
Table 22. Players HER2 Target Drugs Products Offered
Table 23. HER2 Target Drugs Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global HER2 Target Drugs Sales by Geographic Region (2018-2023) & (K Units)
Table 27. Global HER2 Target Drugs Sales Market Share Geographic Region (2018-2023)
Table 28. Global HER2 Target Drugs Revenue by Geographic Region (2018-2023) & ($ millions)
Table 29. Global HER2 Target Drugs Revenue Market Share by Geographic Region (2018-2023)
Table 30. Global HER2 Target Drugs Sales by Country/Region (2018-2023) & (K Units)
Table 31. Global HER2 Target Drugs Sales Market Share by Country/Region (2018-2023)
Table 32. Global HER2 Target Drugs Revenue by Country/Region (2018-2023) & ($ millions)
Table 33. Global HER2 Target Drugs Revenue Market Share by Country/Region (2018-2023)
Table 34. Americas HER2 Target Drugs Sales by Country (2018-2023) & (K Units)
Table 35. Americas HER2 Target Drugs Sales Market Share by Country (2018-2023)
Table 36. Americas HER2 Target Drugs Revenue by Country (2018-2023) & ($ Millions)
Table 37. Americas HER2 Target Drugs Revenue Market Share by Country (2018-2023)
Table 38. Americas HER2 Target Drugs Sales by Type (2018-2023) & (K Units)
Table 39. Americas HER2 Target Drugs Sales by Application (2018-2023) & (K Units)
Table 40. APAC HER2 Target Drugs Sales by Region (2018-2023) & (K Units)
Table 41. APAC HER2 Target Drugs Sales Market Share by Region (2018-2023)
Table 42. APAC HER2 Target Drugs Revenue by Region (2018-2023) & ($ Millions)
Table 43. APAC HER2 Target Drugs Revenue Market Share by Region (2018-2023)
Table 44. APAC HER2 Target Drugs Sales by Type (2018-2023) & (K Units)
Table 45. APAC HER2 Target Drugs Sales by Application (2018-2023) & (K Units)
Table 46. Europe HER2 Target Drugs Sales by Country (2018-2023) & (K Units)
Table 47. Europe HER2 Target Drugs Sales Market Share by Country (2018-2023)
Table 48. Europe HER2 Target Drugs Revenue by Country (2018-2023) & ($ Millions)
Table 49. Europe HER2 Target Drugs Revenue Market Share by Country (2018-2023)
Table 50. Europe HER2 Target Drugs Sales by Type (2018-2023) & (K Units)
Table 51. Europe HER2 Target Drugs Sales by Application (2018-2023) & (K Units)
Table 52. Middle East & Africa HER2 Target Drugs Sales by Country (2018-2023) & (K Units)
Table 53. Middle East & Africa HER2 Target Drugs Sales Market Share by Country (2018-2023)
Table 54. Middle East & Africa HER2 Target Drugs Revenue by Country (2018-2023) & ($ Millions)
Table 55. Middle East & Africa HER2 Target Drugs Revenue Market Share by Country (2018-2023)
Table 56. Middle East & Africa HER2 Target Drugs Sales by Type (2018-2023) & (K Units)
Table 57. Middle East & Africa HER2 Target Drugs Sales by Application (2018-2023) & (K Units)
Table 58. Key Market Drivers & Growth Opportunities of HER2 Target Drugs
Table 59. Key Market Challenges & Risks of HER2 Target Drugs
Table 60. Key Industry Trends of HER2 Target Drugs
Table 61. HER2 Target Drugs Raw Material
Table 62. Key Suppliers of Raw Materials
Table 63. HER2 Target Drugs Distributors List
Table 64. HER2 Target Drugs Customer List
Table 65. Global HER2 Target Drugs Sales Forecast by Region (2024-2029) & (K Units)
Table 66. Global HER2 Target Drugs Revenue Forecast by Region (2024-2029) & ($ millions)
Table 67. Americas HER2 Target Drugs Sales Forecast by Country (2024-2029) & (K Units)
Table 68. Americas HER2 Target Drugs Revenue Forecast by Country (2024-2029) & ($ millions)
Table 69. APAC HER2 Target Drugs Sales Forecast by Region (2024-2029) & (K Units)
Table 70. APAC HER2 Target Drugs Revenue Forecast by Region (2024-2029) & ($ millions)
Table 71. Europe HER2 Target Drugs Sales Forecast by Country (2024-2029) & (K Units)
Table 72. Europe HER2 Target Drugs Revenue Forecast by Country (2024-2029) & ($ millions)
Table 73. Middle East & Africa HER2 Target Drugs Sales Forecast by Country (2024-2029) & (K Units)
Table 74. Middle East & Africa HER2 Target Drugs Revenue Forecast by Country (2024-2029) & ($ millions)
Table 75. Global HER2 Target Drugs Sales Forecast by Type (2024-2029) & (K Units)
Table 76. Global HER2 Target Drugs Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 77. Global HER2 Target Drugs Sales Forecast by Application (2024-2029) & (K Units)
Table 78. Global HER2 Target Drugs Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 79. Roche Basic Information, HER2 Target Drugs Manufacturing Base, Sales Area and Its Competitors
Table 80. Roche HER2 Target Drugs Product Portfolios and Specifications
Table 81. Roche HER2 Target Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 82. Roche Main Business
Table 83. Roche Latest Developments
Table 84. GSK Basic Information, HER2 Target Drugs Manufacturing Base, Sales Area and Its Competitors
Table 85. GSK HER2 Target Drugs Product Portfolios and Specifications
Table 86. GSK HER2 Target Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 87. GSK Main Business
Table 88. GSK Latest Developments
Table 89. Boehringer Digelheim Basic Information, HER2 Target Drugs Manufacturing Base, Sales Area and Its Competitors
Table 90. Boehringer Digelheim HER2 Target Drugs Product Portfolios and Specifications
Table 91. Boehringer Digelheim HER2 Target Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 92. Boehringer Digelheim Main Business
Table 93. Boehringer Digelheim Latest Developments
Table 94. Pfizer Basic Information, HER2 Target Drugs Manufacturing Base, Sales Area and Its Competitors
Table 95. Pfizer HER2 Target Drugs Product Portfolios and Specifications
Table 96. Pfizer HER2 Target Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 97. Pfizer Main Business
Table 98. Pfizer Latest Developments
Table 99. AstraZeneca Basic Information, HER2 Target Drugs Manufacturing Base, Sales Area and Its Competitors
Table 100. AstraZeneca HER2 Target Drugs Product Portfolios and Specifications
Table 101. AstraZeneca HER2 Target Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 102. AstraZeneca Main Business
Table 103. AstraZeneca Latest Developments
Table 104. Seagen Basic Information, HER2 Target Drugs Manufacturing Base, Sales Area and Its Competitors
Table 105. Seagen HER2 Target Drugs Product Portfolios and Specifications
Table 106. Seagen HER2 Target Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 107. Seagen Main Business
Table 108. Seagen Latest Developments
Table 109. MacroGenics Basic Information, HER2 Target Drugs Manufacturing Base, Sales Area and Its Competitors
Table 110. MacroGenics HER2 Target Drugs Product Portfolios and Specifications
Table 111. MacroGenics HER2 Target Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 112. MacroGenics Main Business
Table 113. MacroGenics Latest Developments
Table 114. Takeda Basic Information, HER2 Target Drugs Manufacturing Base, Sales Area and Its Competitors
Table 115. Takeda HER2 Target Drugs Product Portfolios and Specifications
Table 116. Takeda HER2 Target Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 117. Takeda Main Business
Table 118. Takeda Latest Developments
Table 119. Daiichi Sankyo Basic Information, HER2 Target Drugs Manufacturing Base, Sales Area and Its Competitors
Table 120. Daiichi Sankyo HER2 Target Drugs Product Portfolios and Specifications
Table 121. Daiichi Sankyo HER2 Target Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 122. Daiichi Sankyo Main Business
Table 123. Daiichi Sankyo Latest Developments
Table 124. Novartis AG Basic Information, HER2 Target Drugs Manufacturing Base, Sales Area and Its Competitors
Table 125. Novartis AG HER2 Target Drugs Product Portfolios and Specifications
Table 126. Novartis AG HER2 Target Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 127. Novartis AG Main Business
Table 128. Novartis AG Latest Developments
Table 129. RemeGen Basic Information, HER2 Target Drugs Manufacturing Base, Sales Area and Its Competitors
Table 130. RemeGen HER2 Target Drugs Product Portfolios and Specifications
Table 131. RemeGen HER2 Target Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 132. RemeGen Main Business
Table 133. RemeGen Latest Developments
Table 134. Sunshine Guojian Basic Information, HER2 Target Drugs Manufacturing Base, Sales Area and Its Competitors
Table 135. Sunshine Guojian HER2 Target Drugs Product Portfolios and Specifications
Table 136. Sunshine Guojian HER2 Target Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 137. Sunshine Guojian Main Business
Table 138. Sunshine Guojian Latest Developments
Table 139. Hengrui Medicine Basic Information, HER2 Target Drugs Manufacturing Base, Sales Area and Its Competitors
Table 140. Hengrui Medicine HER2 Target Drugs Product Portfolios and Specifications
Table 141. Hengrui Medicine HER2 Target Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 142. Hengrui Medicine Main Business
Table 143. Hengrui Medicine Latest Developments
LIST OF FIGURES
Figure 1. Picture of HER2 Target Drugs
Figure 2. HER2 Target Drugs Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global HER2 Target Drugs Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global HER2 Target Drugs Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. HER2 Target Drugs Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Monoclonal Antibodies
Figure 10. Product Picture of Small Molecule Chemicals
Figure 11. Product Picture of Antibody Drug Conjugate
Figure 12. Global HER2 Target Drugs Sales Market Share by Type in 2022
Figure 13. Global HER2 Target Drugs Revenue Market Share by Type (2018-2023)
Figure 14. HER2 Target Drugs Consumed in Breast Cancer
Figure 15. Global HER2 Target Drugs Market: Breast Cancer (2018-2023) & (K Units)
Figure 16. HER2 Target Drugs Consumed in Colorectal Cancer
Figure 17. Global HER2 Target Drugs Market: Colorectal Cancer (2018-2023) & (K Units)
Figure 18. HER2 Target Drugs Consumed in Stomach Cancer
Figure 19. Global HER2 Target Drugs Market: Stomach Cancer (2018-2023) & (K Units)
Figure 20. HER2 Target Drugs Consumed in Other
Figure 21. Global HER2 Target Drugs Market: Other (2018-2023) & (K Units)
Figure 22. Global HER2 Target Drugs Sales Market Share by Application (2022)
Figure 23. Global HER2 Target Drugs Revenue Market Share by Application in 2022
Figure 24. HER2 Target Drugs Sales Market by Company in 2022 (K Units)
Figure 25. Global HER2 Target Drugs Sales Market Share by Company in 2022
Figure 26. HER2 Target Drugs Revenue Market by Company in 2022 ($ Million)
Figure 27. Global HER2 Target Drugs Revenue Market Share by Company in 2022
Figure 28. Global HER2 Target Drugs Sales Market Share by Geographic Region (2018-2023)
Figure 29. Global HER2 Target Drugs Revenue Market Share by Geographic Region in 2022
Figure 30. Americas HER2 Target Drugs Sales 2018-2023 (K Units)
Figure 31. Americas HER2 Target Drugs Revenue 2018-2023 ($ Millions)
Figure 32. APAC HER2 Target Drugs Sales 2018-2023 (K Units)
Figure 33. APAC HER2 Target Drugs Revenue 2018-2023 ($ Millions)
Figure 34. Europe HER2 Target Drugs Sales 2018-2023 (K Units)
Figure 35. Europe HER2 Target Drugs Revenue 2018-2023 ($ Millions)
Figure 36. Middle East & Africa HER2 Target Drugs Sales 2018-2023 (K Units)
Figure 37. Middle East & Africa HER2 Target Drugs Revenue 2018-2023 ($ Millions)
Figure 38. Americas HER2 Target Drugs Sales Market Share by Country in 2022
Figure 39. Americas HER2 Target Drugs Revenue Market Share by Country in 2022
Figure 40. Americas HER2 Target Drugs Sales Market Share by Type (2018-2023)
Figure 41. Americas HER2 Target Drugs Sales Market Share by Application (2018-2023)
Figure 42. United States HER2 Target Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 43. Canada HER2 Target Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 44. Mexico HER2 Target Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 45. Brazil HER2 Target Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 46. APAC HER2 Target Drugs Sales Market Share by Region in 2022
Figure 47. APAC HER2 Target Drugs Revenue Market Share by Regions in 2022
Figure 48. APAC HER2 Target Drugs Sales Market Share by Type (2018-2023)
Figure 49. APAC HER2 Target Drugs Sales Market Share by Application (2018-2023)
Figure 50. China HER2 Target Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 51. Japan HER2 Target Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 52. South Korea HER2 Target Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 53. Southeast Asia HER2 Target Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 54. India HER2 Target Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 55. Australia HER2 Target Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 56. China Taiwan HER2 Target Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 57. Europe HER2 Target Drugs Sales Market Share by Country in 2022
Figure 58. Europe HER2 Target Drugs Revenue Market Share by Country in 2022
Figure 59. Europe HER2 Target Drugs Sales Market Share by Type (2018-2023)
Figure 60. Europe HER2 Target Drugs Sales Market Share by Application (2018-2023)
Figure 61. Germany HER2 Target Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 62. France HER2 Target Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 63. UK HER2 Target Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 64. Italy HER2 Target Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 65. Russia HER2 Target Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 66. Middle East & Africa HER2 Target Drugs Sales Market Share by Country in 2022
Figure 67. Middle East & Africa HER2 Target Drugs Revenue Market Share by Country in 2022
Figure 68. Middle East & Africa HER2 Target Drugs Sales Market Share by Type (2018-2023)
Figure 69. Middle East & Africa HER2 Target Drugs Sales Market Share by Application (2018-2023)
Figure 70. Egypt HER2 Target Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 71. South Africa HER2 Target Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 72. Israel HER2 Target Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 73. Turkey HER2 Target Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 74. GCC Country HER2 Target Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 75. Manufacturing Cost Structure Analysis of HER2 Target Drugs in 2022
Figure 76. Manufacturing Process Analysis of HER2 Target Drugs
Figure 77. Industry Chain Structure of HER2 Target Drugs
Figure 78. Channels of Distribution
Figure 79. Global HER2 Target Drugs Sales Market Forecast by Region (2024-2029)
Figure 80. Global HER2 Target Drugs Revenue Market Share Forecast by Region (2024-2029)
Figure 81. Global HER2 Target Drugs Sales Market Share Forecast by Type (2024-2029)
Figure 82. Global HER2 Target Drugs Revenue Market Share Forecast by Type (2024-2029)
Figure 83. Global HER2 Target Drugs Sales Market Share Forecast by Application (2024-2029)
Figure 84. Global HER2 Target Drugs Revenue Market Share Forecast by Application (2024-2029)
Figure 1. Picture of HER2 Target Drugs
Figure 2. HER2 Target Drugs Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global HER2 Target Drugs Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global HER2 Target Drugs Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. HER2 Target Drugs Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Monoclonal Antibodies
Figure 10. Product Picture of Small Molecule Chemicals
Figure 11. Product Picture of Antibody Drug Conjugate
Figure 12. Global HER2 Target Drugs Sales Market Share by Type in 2022
Figure 13. Global HER2 Target Drugs Revenue Market Share by Type (2018-2023)
Figure 14. HER2 Target Drugs Consumed in Breast Cancer
Figure 15. Global HER2 Target Drugs Market: Breast Cancer (2018-2023) & (K Units)
Figure 16. HER2 Target Drugs Consumed in Colorectal Cancer
Figure 17. Global HER2 Target Drugs Market: Colorectal Cancer (2018-2023) & (K Units)
Figure 18. HER2 Target Drugs Consumed in Stomach Cancer
Figure 19. Global HER2 Target Drugs Market: Stomach Cancer (2018-2023) & (K Units)
Figure 20. HER2 Target Drugs Consumed in Other
Figure 21. Global HER2 Target Drugs Market: Other (2018-2023) & (K Units)
Figure 22. Global HER2 Target Drugs Sales Market Share by Application (2022)
Figure 23. Global HER2 Target Drugs Revenue Market Share by Application in 2022
Figure 24. HER2 Target Drugs Sales Market by Company in 2022 (K Units)
Figure 25. Global HER2 Target Drugs Sales Market Share by Company in 2022
Figure 26. HER2 Target Drugs Revenue Market by Company in 2022 ($ Million)
Figure 27. Global HER2 Target Drugs Revenue Market Share by Company in 2022
Figure 28. Global HER2 Target Drugs Sales Market Share by Geographic Region (2018-2023)
Figure 29. Global HER2 Target Drugs Revenue Market Share by Geographic Region in 2022
Figure 30. Americas HER2 Target Drugs Sales 2018-2023 (K Units)
Figure 31. Americas HER2 Target Drugs Revenue 2018-2023 ($ Millions)
Figure 32. APAC HER2 Target Drugs Sales 2018-2023 (K Units)
Figure 33. APAC HER2 Target Drugs Revenue 2018-2023 ($ Millions)
Figure 34. Europe HER2 Target Drugs Sales 2018-2023 (K Units)
Figure 35. Europe HER2 Target Drugs Revenue 2018-2023 ($ Millions)
Figure 36. Middle East & Africa HER2 Target Drugs Sales 2018-2023 (K Units)
Figure 37. Middle East & Africa HER2 Target Drugs Revenue 2018-2023 ($ Millions)
Figure 38. Americas HER2 Target Drugs Sales Market Share by Country in 2022
Figure 39. Americas HER2 Target Drugs Revenue Market Share by Country in 2022
Figure 40. Americas HER2 Target Drugs Sales Market Share by Type (2018-2023)
Figure 41. Americas HER2 Target Drugs Sales Market Share by Application (2018-2023)
Figure 42. United States HER2 Target Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 43. Canada HER2 Target Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 44. Mexico HER2 Target Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 45. Brazil HER2 Target Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 46. APAC HER2 Target Drugs Sales Market Share by Region in 2022
Figure 47. APAC HER2 Target Drugs Revenue Market Share by Regions in 2022
Figure 48. APAC HER2 Target Drugs Sales Market Share by Type (2018-2023)
Figure 49. APAC HER2 Target Drugs Sales Market Share by Application (2018-2023)
Figure 50. China HER2 Target Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 51. Japan HER2 Target Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 52. South Korea HER2 Target Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 53. Southeast Asia HER2 Target Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 54. India HER2 Target Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 55. Australia HER2 Target Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 56. China Taiwan HER2 Target Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 57. Europe HER2 Target Drugs Sales Market Share by Country in 2022
Figure 58. Europe HER2 Target Drugs Revenue Market Share by Country in 2022
Figure 59. Europe HER2 Target Drugs Sales Market Share by Type (2018-2023)
Figure 60. Europe HER2 Target Drugs Sales Market Share by Application (2018-2023)
Figure 61. Germany HER2 Target Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 62. France HER2 Target Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 63. UK HER2 Target Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 64. Italy HER2 Target Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 65. Russia HER2 Target Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 66. Middle East & Africa HER2 Target Drugs Sales Market Share by Country in 2022
Figure 67. Middle East & Africa HER2 Target Drugs Revenue Market Share by Country in 2022
Figure 68. Middle East & Africa HER2 Target Drugs Sales Market Share by Type (2018-2023)
Figure 69. Middle East & Africa HER2 Target Drugs Sales Market Share by Application (2018-2023)
Figure 70. Egypt HER2 Target Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 71. South Africa HER2 Target Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 72. Israel HER2 Target Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 73. Turkey HER2 Target Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 74. GCC Country HER2 Target Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 75. Manufacturing Cost Structure Analysis of HER2 Target Drugs in 2022
Figure 76. Manufacturing Process Analysis of HER2 Target Drugs
Figure 77. Industry Chain Structure of HER2 Target Drugs
Figure 78. Channels of Distribution
Figure 79. Global HER2 Target Drugs Sales Market Forecast by Region (2024-2029)
Figure 80. Global HER2 Target Drugs Revenue Market Share Forecast by Region (2024-2029)
Figure 81. Global HER2 Target Drugs Sales Market Share Forecast by Type (2024-2029)
Figure 82. Global HER2 Target Drugs Revenue Market Share Forecast by Type (2024-2029)
Figure 83. Global HER2 Target Drugs Sales Market Share Forecast by Application (2024-2029)
Figure 84. Global HER2 Target Drugs Revenue Market Share Forecast by Application (2024-2029)
